The first patient to undergo recently approved gene therapy for sickle cell disease, Kendric Cromer, has left the hospital. The 12-year-old has been receiving treatment at the Children’s National Hospital in Washington, D.C., United States of America, for the past 44 days, but left the facility on Monday, reports the New York Times. Sickle cell